A Double-Blinded, Placebo Controlled, Single Ascending Dose Study for Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Subcutaneous Administration of Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in Healthy Obese Subjects

被引：6
|
作者：
Choi, Jae Duk
Baek, Seungjae
Kim, Youngmin
Eun, Kahee
Kwon, Se Chang
Morrow, Linda
Hompesch, Marcus
Kang, Jahoon
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-982-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
982-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ANTI -FIBROTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN BDL-INDUCED MOUSE MODEL OF LIVER FIBROSIS
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Seon Myeong
    Lee, Jong Suk
    Kwon, Hyunjoo
    Lee, Jong Soo
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1009 - 1010
  • [32] THERAPEUTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN CDHFD-INDUCED MOUSE MODEL OF NASH AND FIBROSIS MICE
    Choi, Jaehyuk
    Lee, Seon Myeong
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Jong Suk
    Kwon, Hyunjoo
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1039 - 1039
  • [33] Anti-fibrotic effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in BDL-induced liver fibrosis mice
    Kim, J.
    Jo, H.
    Lee, J.
    Lee, S.
    Kwon, H.
    Lee, J.
    Bae, S.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S417 - S418
  • [34] Neuroprotective Effects of HM15211, a Novel Long-Acting GLP-1/Glucagon/GIP Tri-Agonist in the MPTP Parkinson's Disease Mouse Model
    Lee, Young Mi
    Lee, Sang Hyun
    Kim, Jeong A.
    Choi, In Young
    Kim, Young Hoon
    Kwon, Se Chang
    DIABETES, 2017, 66 : A303 - A303
  • [35] Potent Body Weight Loss and Efficacy in a NASH Animal Model by a Novel Long-Acting GLP-1/Glucagon/GIP Tri-Agonist (HM15211)
    Choi, In Young
    Lee, Jong Suk
    Kim, Jung Kuk
    Park, Young Jin
    Jung, Sungyoub
    Kim, Young Hoon
    Kwon, Se Chang
    DIABETES, 2017, 66 : A304 - A304
  • [36] Neuroprotective effects of HM15211, a novel long-acting GLP-1/Glucagon/GIP tri-agonist in the MPTP Parkinson's disease mouse model
    Lee, Y.
    Lee, S. -H.
    Kim, J.
    Choi, I.
    Kim, Y.
    Kwon, S.
    DIABETOLOGIA, 2017, 60 : S579 - S579
  • [37] ANTI -INFLAMMATION AND ANTI-FIBROSIS EFFECTS OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST TRIPLE AGONIST (HM15211) IN AMLN/TAA INDUCED MOUSE MODEL OF LIVER INFLAMMATION AND FIBROSIS
    Lee, Jong Suk
    Jo, Hyo Sang
    Kim, Jung Kuk
    Lee, Seon Myeong
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1010 - 1011
  • [38] Novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) exhibits anti-inflammatory and - fibrotic effects in AMLN/TAA induced liver inflammation and fibrosis mice
    Jo, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S417 - S417
  • [39] Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects
    Jin, Jiangli
    Cui, Gang
    Mi, Na
    Wu, Wei
    Zhang, Xin
    Xiao, Chunyan
    Wang, Jing
    Qiu, Xueying
    Han, Mai
    Li, Ziyan
    Wang, Lei
    Lu, Tong
    Niu, Huikun
    Wu, Zhaoxi
    Li, Jintong
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 185
  • [40] HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist, Exhibits Anti-inflammatory and Fibrotic Effects in AMLN/TAA-Induced Liver Inflammation and Fibrosis Mice
    Kim, Jung Kuk
    Lee, Jong Suk
    Park, Eunjin
    Lee, Jongsoo
    Bae, Sungmin
    Kim, Daejin
    Choi, In Young
    DIABETES, 2020, 69
12345